Refex Industries Ltd. has confirmed the lapse of 11.17 million convertible warrants, resulting in the forfeiture of ₹130.69 crore in upfront payments. Holders of these warrants failed to pay the remaining 75% of the exercise price by the due date, meaning they cannot convert them into equity shares. The company stated that this situation will not affect its paid-up share capital.
Details of the Warrant Lapse
The lapsed warrants, totaling 11,170,000, were originally allotted on November 7, 2023. Their exercise period, which allowed conversion into equity, concluded without the holders meeting the payment obligations. The failure to remit the balance 75% of the consideration led to the forfeiture of the initial 25% subscription amount, amounting to ₹130.69 crore.
Impact on Refex Industries
The forfeiture represents a significant cash inflow of ₹130.69 crore for Refex Industries, enhancing its liquidity position. Additionally, the non-conversion means no new shares will be issued, thus avoiding any dilution of equity for existing shareholders.
Prior Capital Raising
This current event concerns a separate issuance of convertible warrants. It is distinct from Refex Industries' Qualified Institutions Placement (QIP) in November 2023, which successfully raised approximately ₹300 crore to fund business expansion and working capital.
Future Considerations
Warrant holders lose their right to convert the specified warrants into equity. The Board of Directors is set to pass a resolution on the accounting treatment or utilization of the forfeited funds. Investors will likely observe the company's execution capabilities in capital raising and its future strategic announcements.
Industry Peer Landscape
Refex Industries operates within the refrigerant and industrial gases sector. Key competitors in this space include Gujarat Fluorochemicals Ltd., known for its presence in refrigerants and fluorochemicals, and Linde India Ltd., a prominent provider of industrial and medical gases.
